Eculizumab for atypical hemolytic-uremic syndrome / Jens Nürnberger, Thomas Philipp, Oliver Witzke, Anabelle Opazo Saez, Udo Vester, Hideo Andreas Baba, Andreas Kribben, Lothar Bernd Zimmerhackl, Andreas R. Janecke, Mato Nagel, Michael Kirschfink
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
January 29, 2009 2009 |
|---|---|
| Erschienen: |
January 29, 2009 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:360 |
|---|---|
| Enthalten in: |
The New England journal of medicine - 360(2009), 5, Seite 542-544 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nürnberger, Jens, 1969- [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Gesehen am 18.06.2021 |
|---|
| Umfang: |
3 |
|---|
| doi: |
10.1056/NEJMc0808527 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1760802425 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | 1760802425 | ||
| 003 | DE-627 | ||
| 005 | 20220819233949.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210618s2009 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1056/NEJMc0808527 |2 doi | |
| 035 | |a (DE-627)1760802425 | ||
| 035 | |a (DE-599)KXP1760802425 | ||
| 035 | |a (OCoLC)1341416709 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nürnberger, Jens |d 1969- |e verfasserin |0 (DE-588)121691098 |0 (DE-627)081470525 |0 (DE-576)292832451 |4 aut | |
| 245 | 1 | 0 | |a Eculizumab for atypical hemolytic-uremic syndrome |c Jens Nürnberger, Thomas Philipp, Oliver Witzke, Anabelle Opazo Saez, Udo Vester, Hideo Andreas Baba, Andreas Kribben, Lothar Bernd Zimmerhackl, Andreas R. Janecke, Mato Nagel, Michael Kirschfink |
| 264 | 1 | |c January 29, 2009 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.06.2021 | ||
| 650 | 4 | |a Adult | |
| 650 | 4 | |a Antibodies, Monoclonal | |
| 650 | 4 | |a Antibodies, Monoclonal, Humanized | |
| 650 | 4 | |a Complement C3b Inactivator Proteins | |
| 650 | 4 | |a Complement C5 | |
| 650 | 4 | |a Complement Factor H | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Hemolytic-Uremic Syndrome | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Immunologic Factors | |
| 650 | 4 | |a Kidney | |
| 650 | 4 | |a Kidney Failure, Chronic | |
| 650 | 4 | |a Kidney Transplantation | |
| 650 | 4 | |a Mutation, Missense | |
| 650 | 4 | |a Recurrence | |
| 650 | 4 | |a Sequence Deletion | |
| 700 | 1 | |a Philipp, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Witzke, Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Opazo Saez, Anabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Vester, Udo |e verfasserin |4 aut | |
| 700 | 1 | |a Baba, Hideo Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Kribben, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Zimmerhackl, Lothar Bernd |e verfasserin |4 aut | |
| 700 | 1 | |a Janecke, Andreas R. |e verfasserin |4 aut | |
| 700 | 1 | |a Nagel, Mato |e verfasserin |4 aut | |
| 700 | 1 | |a Kirschfink, Michael |e verfasserin |0 (DE-588)120927152 |0 (DE-627)080974457 |0 (DE-576)292452411 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d Waltham, Mass. : MMS, 1928 |g 360(2009), 5, Seite 542-544 |h Online-Ressource |w (DE-627)266889484 |w (DE-600)1468837-2 |w (DE-576)075962454 |x 1533-4406 |7 nnns |
| 773 | 1 | 8 | |g volume:360 |g year:2009 |g number:5 |g pages:542-544 |g extent:3 |
| 856 | 4 | 0 | |u https://doi.org/10.1056/NEJMc0808527 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nejm.org/doi/full/10.1056/NEJMc0808527 |x Verlag |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ILN_2013 | ||
| 912 | |a ISIL_DE-16-250 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_39 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_63 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_95 | ||
| 912 | |a GBV_ILN_100 | ||
| 912 | |a GBV_ILN_101 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_110 | ||
| 912 | |a GBV_ILN_120 | ||
| 912 | |a GBV_ILN_151 | ||
| 912 | |a GBV_ILN_161 | ||
| 912 | |a GBV_ILN_168 | ||
| 912 | |a GBV_ILN_170 | ||
| 912 | |a GBV_ILN_206 | ||
| 912 | |a GBV_ILN_213 | ||
| 912 | |a GBV_ILN_230 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_293 | ||
| 912 | |a GBV_ILN_602 | ||
| 912 | |a GBV_ILN_2001 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_2007 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a GBV_ILN_2011 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a GBV_ILN_2021 | ||
| 912 | |a GBV_ILN_2446 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4035 | ||
| 912 | |a GBV_ILN_4037 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4249 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4307 | ||
| 912 | |a GBV_ILN_4313 | ||
| 912 | |a GBV_ILN_4322 | ||
| 912 | |a GBV_ILN_4323 | ||
| 912 | |a GBV_ILN_4324 | ||
| 912 | |a GBV_ILN_4325 | ||
| 912 | |a GBV_ILN_4338 | ||
| 912 | |a GBV_ILN_4367 | ||
| 912 | |a GBV_ILN_4700 | ||
| 936 | u | w | |d 360 |j 2009 |e 5 |h 542-544 |g 3 |
| 951 | |a AR | ||
| 952 | |d 360 |j 2009 |e 5 |h 542-544 |g 3 | ||
| 980 | |2 2013 |1 01 |x DE-16-250 |b 3939408042 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 18-06-21 | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2009 | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1439624976 |a Briefe (Letter) | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_11 | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_3 | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1450201806 |a Kirschfink, Michael | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416741488 |a Institut für Immunologie und Serologie | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
| 982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_11 | ||